Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in YouthRajen Mody, Arul M. Chinnaiyan, Yi-Mi Wu et al.|JAMA|2015Cited by 416
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 TrialShengxiang Ren, Caicun Zhou, Yanjun Zhang et al.|Journal of Thoracic Oncology|2021Cited by 311
LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic ResponseFuming Li, Hongbin Ji, Xiangkun Han et al.|Cancer Cell|2015Cited by 167
Cuprotosis Programmed-Cell-Death-Related lncRNA Signature Predicts Prognosis and Immune Landscape in PAAD PatientsHao Chi, Gang Tian, Gaoge Peng et al.|Cells|2022Cited by 66
Intestinal mucosal barrier repair and immune regulation with an AI-developed gut-restricted PHD inhibitorYanyun Fu, Alex Zhavoronkov, Xiao Ding et al.|Nature Biotechnology|2024Cited by 45